Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] DUX4-fl gene, which encodes a paired homeobox domain transcription factor, is the primary mediator of FSHD pathology, but the mechanism is unknown. This is mainly due to the lack of […]
Our webinar with Dr. Tina Duong remains timely and important for families with FSHD. In it, she focuses on individuals with early-onset FSHD, meaning those who develop symptoms in their […]
[…] (foreground) in the auditorium with medical students in the background. I was formally diagnosed with FSHD in January 2019. Â At that time I knew I was in trouble, because I […]
We know that patients are the experts when it comes to understanding the impacts of FSHD on their health and well-being. That’s why when we saw many discussions on social […]
[…] that it is launching an international Phase 2 clinical trial for facioscapulohumeral muscular dystrophy ( FSHD). The trial, which is called MANOEUVRE, will take place in Denmark, Italy, the UK, […]
